Nephrology Flashcards
Glomerulonephritis
Renal biopsies show any changes of glomerulonephritis along with renal scarring from longstanding hypertension or urinary tract infections
Nephrogenic Diabetes Insipidus
V2 ADH mutation is usually X linked recessive.
Nephrogenic DI related to vasopressin-2 receptor mutation is X linked. This fits best with only male members of the family being affected by the condition. Nephrogenic DI may also occur as a sporadic condition or be autosomal recessive, although drugs are the commonest precipitants.
Autosomal recessive nephrogenic DI is related to mutations in the aquaporin-2 gene,
Nephrotic Syndrome
The triad of proteinuria, hypoalbuminaemia and oedema typifies the nephrotic syndrome.
The minimum threshold for proteinuria which is defined as ‘nephrotic’ is 300 mg/mmol.
Symptomatic Nephrotic syndrome caused by membranous nephropathy
Immunosuppression in the form of alternating steroids and cyclophosphamide is indicated in those patients with symptomatic nephrotic syndrome caused by membranous nephropathy
ADPKD
Abdominal ultrasound has a sensitivity approaching 100% for autosomal dominant polycystic kidney disease (ADPKD) patients above 20 years of age.
Rhabdomyolysis
The biochemical features of rhabdomyolysis are raised creatine kinase, hypocalcaemia (especially early after injury), hyperkalaemia and acute kidney injury.
Phosphate excretion in dialysis
Dialysis is able to remove about 2700 mg of phosphate per week in a patient who is anuric. This is half of the normal kidney’s ability.
Staghorn calculus ( Struvite)
Ammonium magnesium phosphate
- Associated with proteus infections.
- Urease inhibitors + Abx
Renal stones
- Cystine stones- cystinuria
- Oxalate stones- Short Bowel syndrome
- Calcium phosphate stones- Renal tubular acidosis
- Urate stones- Gout
- Struvite stones- Proteus
Minimal change disease
Features
- nephrotic syndrome
- normotension - hypertension is rare
- highly selective proteinuria
-Renal biopsy
normal glomeruli on light microscopy.
electron microscopy shows fusion of podocytes and effacement of foot processes
Management
- oral corticosteroids: majority of cases (80%) are steroid-responsive
- cyclophosphamide is the next step for steroid-resistant cases